Episode 505 : ASCO 2026 - RAMPART

Podcast: The Uromigos · The Uromigos

Opublikowano: 2026-05-30

James Larkin joins us to discuss the durvalumab monotherapy arm from RAMPART and we discuss the role of CTLA-4 inhibition broadly and how these data contribute to the adjuvant RCC landscape.